Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-Thalidomide is the R-enantiomer of Thalidomide, has sedative properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | (R)-Thalidomide is the R-enantiomer of Thalidomide, has sedative properties. |
In vitro | With the affinity of (R)-Thalidomide by the MIP present surface capture, that is more strongly than the other forms. In the case of (R)-Thalidomide, it is found to bind to the selective sites of the MIP more strongly than the other which reflects their different biological entities[1]. The (S)-Thalidomide imprints MIP nanoparticles exerted a greater cytotoxic effect on the caco-2 cells than the (R)-Thalidomide imprinted MIPs[1]. |
In vivo | Effectiveness of oral thalidomide alone, and with intraperitoneal BCNU or cisplatin combination chemotherapy, is assessed after several weeks treatment. Both serum and tissue concentrations of (R)-thalidomide are 40-50% greater than those of (S)-thalidomide. Co-administration of BCNU or cisplatin with thalidomide did not alter the concentration enantioselectivity[1]. |
Synonyms | (R)-(+)-Thalidomide |
Molecular Weight | 258.23 |
Formula | C13H10N2O4 |
CAS No. | 2614-06-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-Thalidomide 2614-06-4 Others (R) Thalidomide Thalidomide (R)Thalidomide (R)-(+)-Thalidomide inhibitor inhibit